Rezolute (RZLT) Current Assets (2011 - 2026)
Rezolute (RZLT) posted Current Assets of $122.0 million for Q1 2026, down 9.66% sequentially from $135.1 million in Q4 2025, and up 37.54% YoY from $88.7 million in Q1 2025.
Rezolute (RZLT) Current Assets (2011 - 2026) Analysis & Trends
Rezolute has reported Current Assets for 16 years, with the latest figure at $122.0 million in Q1 2026.
- Quarterly Current Assets rose 37.54% year-over-year to $122.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $122.0 million (up 37.54% YoY) and the FY2025 annual result came in at $171.1 million, up 33.03% from the prior year.
- Current Assets slipped to $122.0 million in Q1 2026 per RZLT's latest filing, from $135.1 million in the prior quarter.
- Over five years, Current Assets peaked at $171.1 million in Q2 2025 and troughed at $64.3 million in Q1 2022.
- A 5-year average of $118.8 million and a median of $110.2 million in 2024 frame the typical range for Current Assets.
- The sharpest annual moves came in 2022 and 2023: Current Assets soared 305.86% in 2022, then sank 34.9% in 2023.
- Over 5 years, Current Assets stood at $147.6 million in 2022, then sank by 34.9% to $96.1 million in 2023, then advanced by 2.72% to $98.7 million in 2024, then surged by 36.89% to $135.1 million in 2025, then dropped by 9.66% to $122.0 million in 2026.
- According to Business Quant data, Current Assets over the past three periods registered $122.0 million, $135.1 million, and $154.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 8.07 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 4.03 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 7.22 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 11.83 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 1.76 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 4.62 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.63 Bn |
| 10 | Rezolute | 442.94 Mn | 442.94 Mn | - | 122.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 122.05 Mn |
| Dec 31, 2025 | 135.11 Mn |
| Sep 30, 2025 | 154.71 Mn |
| Jun 30, 2025 | 171.15 Mn |
| Mar 31, 2025 | 88.74 Mn |
| Dec 31, 2024 | 98.69 Mn |
| Sep 30, 2024 | 110.18 Mn |
| Jun 30, 2024 | 128.65 Mn |
| Mar 31, 2024 | 82.21 Mn |
| Dec 31, 2023 | 96.09 Mn |
| Sep 30, 2023 | 102.65 Mn |
| Jun 30, 2023 | 104.91 Mn |
| Mar 31, 2023 | 105.53 Mn |
| Dec 31, 2022 | 147.61 Mn |
| Sep 30, 2022 | 155.63 Mn |
| Jun 30, 2022 | 152.10 Mn |
| Mar 31, 2022 | 64.33 Mn |
| Dec 31, 2021 | 78.10 Mn |
| Sep 30, 2021 | 38.35 Mn |
| Jun 30, 2021 | 41.99 Mn |